Trial Profile
A phase IV study on Pegasys plus Ribavirin in the treatment of non-respond Chronic Hepatitis C patients.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Jul 2010 New trial record